Collegium Pharmaceutical, Inc.
COLL
$27.27
$0.220.81%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 34.29% | -52.39% | -29.25% | -13.23% | 54.79% |
| Total Depreciation and Amortization | 35.37% | 17.71% | 0.09% | -0.08% | -4.55% |
| Total Amortization of Deferred Charges | 17.88% | -24.69% | -9.89% | -9.32% | -7.58% |
| Total Other Non-Cash Items | -198.95% | -79.40% | 392.69% | -56.77% | 15.04% |
| Change in Net Operating Assets | 126.28% | -2,784.71% | 60.52% | -167.17% | -123.81% |
| Cash from Operations | 1,040.59% | -113.35% | 8.82% | -15.55% | -0.92% |
| Capital Expenditure | -133.61% | 9.63% | 52.46% | -246.34% | -152.31% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -159.47% | 317.91% | 50.82% | 29.57% | -563.64% |
| Cash from Investing | 95.28% | -2,695.45% | 50.87% | 27.77% | -556.65% |
| Total Debt Issued | -96.22% | -- | -- | -- | -- |
| Total Debt Repaid | 90.19% | -108.25% | -72.48% | 0.00% | 0.00% |
| Issuance of Common Stock | -72.10% | -89.16% | 25.39% | 40.77% | 446.37% |
| Repurchase of Common Stock | -17,719.72% | 99.65% | -217.50% | 48.98% | 49.71% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -127.70% | 230.49% | -110.93% | 20.17% | 28.91% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 129.01% | -95.52% | -439.00% | 47.22% | 22.33% |